
Quest Diagnostics Experiences Revision in Stock Evaluation Amidst Market Dynamics
2025-10-07 20:13:22Quest Diagnostics, Inc. has recently seen a slight decline in stock price, currently at $178.43. Over the past year, the company achieved an 18.33% return, outperforming the S&P 500. Technical indicators show mixed signals, with bullish trends on monthly evaluations and a sideways movement expected in the short term.
Read MoreIs Quest Diagnostics, Inc. technically bullish or bearish?
2025-10-07 12:11:58As of 3 October 2025, the technical trend for Quest Diagnostics, Inc. has changed from bullish to mildly bullish. The weekly and monthly MACD indicators are bullish, while the Bollinger Bands show a mildly bullish stance in both time frames. The daily moving averages also indicate a mildly bullish trend. However, the RSI shows no signal on both weekly and monthly charts, and Dow Theory indicates no trend in either time frame. In terms of performance, Quest Diagnostics has outperformed the S&P 500 year-to-date and over the past year, with returns of 18.28% and 18.33% respectively, compared to the S&P 500's 14.18% and 17.82%. However, it has underperformed over longer periods, particularly in the 3-year and 5-year comparisons. Overall, the current technical stance is mildly bullish, supported by several bullish indicators, despite some mixed signals....
Read MoreIs Quest Diagnostics, Inc. technically bullish or bearish?
2025-10-06 12:02:17As of 3 October 2025, the technical trend for Quest Diagnostics, Inc. has changed from bullish to mildly bullish. The weekly and monthly MACD indicators are bullish, while the Bollinger Bands show a mildly bullish stance in both time frames. The daily moving averages are also mildly bullish. However, the RSI does not provide a signal, and Dow Theory indicates no trend on both weekly and monthly levels. In terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of -5.11% and -0.10% compared to 1.09% and 4.15% for the index, respectively. However, it has outperformed the S&P 500 year-to-date and over the past year. Overall, the current technical stance is mildly bullish, supported by several bullish indicators, but tempered by recent underperformance in shorter time frames....
Read MoreIs Quest Diagnostics, Inc. technically bullish or bearish?
2025-10-05 11:47:07As of 3 October 2025, the technical trend for Quest Diagnostics, Inc. has changed from bullish to mildly bullish. The weekly MACD and KST indicators are bullish, while the moving averages indicate a mildly bullish stance on the daily timeframe. Bollinger Bands also reflect a mildly bullish outlook on both weekly and monthly timeframes. However, the RSI shows no signal, and Dow Theory indicates no trend on both weekly and monthly scales. In terms of performance, Quest Diagnostics has underperformed the S&P 500 over the past week and month, with returns of -5.11% and -0.10% respectively, while it has outperformed the index year-to-date and over the past year. Overall, the current technical stance is mildly bullish, supported by several bullish indicators, but with some caution due to recent underperformance....
Read More
Quest Diagnostics Hits New 52-Week High at $191.45, Surges 34.71%
2025-10-01 16:33:20Quest Diagnostics, Inc. has achieved a new 52-week high, reflecting its strong market performance with a notable annual increase. The company, with a market capitalization of approximately USD 29.72 billion, maintains a solid valuation and a commitment to shareholder returns through a significant dividend yield.
Read More
Quest Diagnostics Hits New 52-Week High of $189.23, Reflecting Strong Performance
2025-09-29 14:17:06Quest Diagnostics, Inc. achieved a new 52-week high of USD 189.23 on September 26, 2025, reflecting strong market performance with a 33.59% increase over the past year. The company, with a market cap of USD 29,720 million, features a P/E ratio of 28.00 and a dividend yield of 87.16%.
Read More
Quest Diagnostics Hits New 52-Week High at $187.96, Surpassing Previous Low
2025-09-24 13:18:31Quest Diagnostics, Inc. achieved a new 52-week high of USD 187.96 on September 23, 2025, reflecting strong market performance with a 32.16% increase over the past year. The company, with a market cap of USD 29,720 million, demonstrates solid financial health through various metrics, including a notable dividend yield.
Read MoreIs Quest Diagnostics, Inc. technically bullish or bearish?
2025-09-20 19:12:04As of 11 September 2025, the technical trend for Quest Diagnostics, Inc. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are both bullish, and the Bollinger Bands also reflect a bullish stance in both time frames. The daily moving averages confirm a bullish trend, while the KST is bullish on both weekly and monthly charts. The On-Balance Volume (OBV) is bullish weekly, although it shows no trend monthly. The Dow Theory indicates a mildly bullish stance on the weekly chart but no trend on the monthly. In terms of performance, Quest Diagnostics has outperformed the S&P 500 year-to-date with a return of 21.52% compared to the S&P 500's 12.22%. However, over the longer term, the stock has underperformed the index over the 3-year, 5-year, and 10-year periods. Overall, the current technical stance is bullish, indicating strong upward momentum....
Read MoreIs Quest Diagnostics, Inc. overvalued or undervalued?
2025-09-20 17:46:09As of 30 June 2025, the valuation grade for Quest Diagnostics, Inc. has moved from attractive to fair. This suggests that the company is fairly valued at present. Key valuation ratios include a P/E ratio of 28, an EV to EBITDA of 17.29, and a Price to Book Value of 4.09. In comparison, peers such as IQVIA Holdings, Inc. have a higher P/E of 36.39, while Laboratory Corp. of America Holdings has a P/E of 29.20, indicating that Quest Diagnostics is positioned competitively within its industry. In terms of recent performance, Quest Diagnostics has achieved a year-to-date return of 21.52%, significantly outperforming the S&P 500's 12.22% during the same period, although it lags behind the S&P 500 over longer horizons like 3 years and 5 years. Overall, the current valuation metrics suggest that Quest Diagnostics is fairly valued in the market....
Read More





